PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
M Hertl Selected Research
Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
12/2001
Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).
09/2001
Autoreactive T cells as potential targets for immunotherapy of autoimmune bullous skin diseases.
Articles by Research Topic
Disease
5
Pemphigus (Pemphigus Vulgaris)
10/2006 - 06/2001
3
Necrosis
08/2005 - 02/2004
2
Skin Diseases
10/2008 - 08/2000
2
Bullous Pemphigoid (Pemphigoid)
06/2002 - 05/2000
2
Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
12/2001 - 09/2001
1
Anaphylaxis (Anaphylactic Shock)
05/2008
1
Urticaria (Hives)
05/2008
1
Death (Near-Death Experience)
12/2007
1
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2007
1
Granuloma Annulare
03/2005
1
Pyoderma Gangrenosum
02/2004
1
Hemophilia A (Haemophilia)
06/2002
1
Contact Dermatitis (Eczema, Contact)
11/2001
1
Benign Mucous Membrane Pemphigoid (Cicatricial Pemphigoid)
08/2000
1
Hypersensitivity (Allergy)
02/2000
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2000
Drug/Important Bio-Agent (IBA)
5
Autoantibodies
IBA
10/2006 - 05/2000
4
infliximab (Remicade)
FDA Link
08/2005 - 12/2001
3
Immunoglobulin G (IgG)
IBA
06/2001 - 05/2000
2
Desmoglein 3
IBA
02/2002 - 06/2001
2
Immunoglobulin A (IgA)
IBA
06/2001 - 08/2000
2
Immunoglobulin E (IgE)
IBA
06/2001 - 08/2000
1
Antibodies
IBA
10/2008
1
Epoxy Resins
IBA
05/2008
1
alefacept (Amevive)
FDA Link
01/2007
1
Methotrexate (Mexate)
FDA Link
Generic
01/2007
1
Desmogleins
IBA
10/2006
1
Tryptophan (L-Tryptophan)
FDA Link
09/2003
1
Factor VIII (Coagulation Factor VIII)
IBA
06/2002
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2001
1
Nickel
IBA
11/2001
1
Ions
IBA
02/2000
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2000
Therapy/Procedure
1
Kidney Transplantation
12/2007
1
Immunotherapy
09/2001